4
Changes in Ownership
Transcode Therapeutics, Inc. Filed Acc 0001104659-24-072820
Options or other derivatives
- Interim CEO, CFO acquired 650,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Fitzgerald Thomas A Interim CEO, CFO | 2024-06-14 | Grant or award · Stock Option (right to buy) | +650,000 | 650,000 | D | ||
Loading xslF345X05/tm2417512-2_4seq1.xml…